Telix Pharmaceuticals Limited
General ticker "TLPPF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.9B (TTM average)
Telix Pharmaceuticals Limited does not follow the US Stock Market performance with the rate: -41.6%.
Estimated limits based on current volatility of 1.5%: low 7.73$, high 7.97$
Factors to consider:
- Total employees count: 200000 as of 2024
Short-term TLPPF quotes
Long-term TLPPF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | AUD502.55MM | AUD783.21MM | AUD1,246.06MM |
| Operating Expenses | AUD450.66MM | AUD701.08MM | AUD1,218.52MM |
| Operating Income | AUD51.89MM | AUD82.13MM | AUD27.54MM |
| Non-Operating Income | AUD-48.80MM | AUD-26.07MM | AUD-35.70MM |
| Interest Expense | AUD13.56MM | AUD21.46MM | AUD56.92MM |
| R&D Expense | AUD128.84MM | AUD121.03MM | AUD265.47MM |
| Income(Loss) | AUD3.09MM | AUD56.06MM | AUD-8.16MM |
| Taxes | AUD-2.12MM | AUD6.14MM | AUD2.88MM |
| Profit(Loss)* | AUD5.21MM | AUD99.84MM | AUD-11.05MM |
| Stockholders Equity | AUD148.91MM | AUD568.21MM | AUD622.65MM |
| Inventory | AUD17.31MM | AUD38.14MM | AUD55.58MM |
| Assets | AUD398.30MM | AUD1,516.43MM | AUD1,771.98MM |
| Operating Cash Flow | AUD23.88MM | AUD43.03MM | AUD-26.81MM |
| Capital expenditure | AUD10.79MM | AUD34.03MM | AUD58.78MM |
| Investing Cash Flow | AUD-25.49MM | AUD-135.17MM | AUD-443.24MM |
| Financing Cash Flow | AUD10.19MM | AUD638.92MM | AUD-5.77MM |
| Earnings Per Share** | AUD0.02 | AUD0.30 | AUD-0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.